medisonal group logo

Welcome to Medisonal: Transforming Healthcare Through Innovation

About Medisonal Group

Shot of a doctor showing a patient some information on a digital tablet

At the intersection of compassion, innovation, and healthcare evolution; The Medisonal Group is pioneering transformative change in the healthcare sector. Headquartered in the UK, Medisonal Ltd presents itself as a patient-centric company, committed to advancing healthcare through ground-breaking solutions and unwavering values.

The Medisonal Group operates with the single mission: The provision of unparalleled support to patients and healthcare professionals, looking to navigate the often-misunderstood realm of unlicensed medicines. Given that there was a shift in how society worked and how one got support, we too moved with the times and helped to facilitate online consultations and meetings for patients seeking treatment, thereby alleviating the pressure on healthcare systems. 

Medisonal’s evolution is a response to the shifting healthcare landscape that emerged post the Global pandemic in 2020. In the wake of unprecedented challenges, our ethos was brought to life.

Our flagship educational platform, the Medisonal Institute of Education (MIE), is a testament to our commitment to knowledge dissemination. Hosting 20 live modules, MIE delves into alternative treatments, from cannabinoids to dedicated modules on psychedelics, extending its reach even to the veterinary domain. 

Our M3 platform, meticulously crafted for consultants, streamlines the prescribing process of controlled drugs, while the M2 platform provides patients with a seamless experience to manage appointments, renew prescriptions, and track symptoms. 

Guided by our dedicated R&D arm, operated by Liberum Health, we are pioneering drug delivery technology in the women’s health market, securing patents for bespoke devices that mark the future of healthcare.

Doctor typing information on Laptop in Hospital office focus on Stethoscope
Medisonal clinic logo

For Doctors

For Investors

Scroll to Top